Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

DoW Reconstructive Transplant, Investigator-Initiated Research Award

Active
HT942526RTRPIIRAGrant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The fiscal year 2026 Reconstructive Transplant Research Program Investigator-Initiated Research Award, solicitation number HT942526RTRPIIRA, provides funding for studies aimed at improving reconstructive transplant research, patient care, and quality of life. Managed by the Defense Health Agency Contracting Activity under the Department of Defense, the program supports a broad scope of research ranging from basic and preclinical animal models to clinical research in human subjects, though it explicitly excludes clinical trials. All proposals must align with FY26 RTRP Focus Areas and demonstrate military-relevant utility by addressing the healthcare needs of Service Members, Veterans, and their families. Applicants are required to provide preliminary or published data to support their research rationale and must implement a rigorous study design with a strong statistical plan to ensure reproducibility and translational feasibility. The deadline for responses is November 4, 2026. While collaboration with military researchers and clinicians is encouraged, it is not a mandatory requirement for submission.

General Info

FY26 RTRP funding for reconstructive transplant research for military members; deadline November 4, 2026.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(1)

HT942526RTRPIIRA_GG.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressUSA
Contacts
Teresa M Parker-ReeserGrants Officer

Full Description

Show more

Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials.


Distinctive Features:

·        Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances.

·        Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational feasibility. A strong statistical plan with appropriate power analysis is important.

·        Impact: Project results should have the potential for long- and short-term impact on the reconstructive transplant research field and/or patient community. Projects should address at least one of the FY26 RTRP Focus Areas.

·        Preliminary Data: Preliminary and/or published data that are relevant to reconstructive transplantation and support the rationale for the proposed research must be included.

·        Military Relevance: All projects must be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their Family members, caregivers, or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged but not required.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ARMY OPEN SOLICITATION (AOS)
Solicitation # W9128Z-25-S-A002
The Army Open Solicitation (AOS), identified by solicitation number W9128Z-25-S-A002, is an indefinite, open solicitation issued by the U.S. Army Contracting Command – Aberdeen Proving Ground to rapidly acquire innovative commercial technologies and research-driven solutions across all Army mission areas. Designed to revitalizing the industrial base and enhancing Warfighter lethality, the solicitation leverages a flexible acquisition framework under multiple FAR, DFARS, and U.S. Code authorities, including Other Transactions, Commercial Solutions Opening, and prototype authorities. It supports both Active Capability Gap submissions and periodic Calls for Solutions, with responses evaluated based on technical merit, feasibility, schedule, price estimation, viability, and desirability using a trade-off approach rather than lowest price technically acceptable. The solicitation remains open indefinitely until canceled, with recent amendments through March 2026 expanding and clarifying Army Example Areas, refining submission procedures, and updating contracting information including Active Capability Gap mailboxes. All submissions must adhere to strict formatting requirements, including a single PDF submission not exceeding five pages or fifteen slides, with mandatory inclusion of an executive summary, company information, and rough order of magnitude cost and schedule estimates. Offerors must be registered in SAM, use WAWF for invoicing, and comply with stringent data storage and security requirements, including U.S.-only data hosting and full organizational conflict of interest disclosures. The solicitation encourages participation from small businesses, nontraditional defense contractors, and nonprofit research institutions, with specific certifications required through the Affirmation of Business Status Certification. Performance may occur at government facilities including Aberdeen Proving Ground and other CONUS/OCONUS locations as directed, with award timing anticipated in fiscal year 2026, and support expected through 2032. No fixed contract value is provided, as pricing is determined through competitive evaluation of commercial proposals under the solicitation's open-ended structure.
W6QK Acc-Apg Contr Ctr

POSTED

about 10 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Solicitation # 97469
The Centers for Disease Control and Prevention (CDC), through the National Center for Emerging and Zoonotic Infectious Diseases, is soliciting quotations for Request for Quotation (RFQ) No. 75D301-26-Q-79208. This is a Time-and-Materials (T&M) contract for professional services to conduct two comprehensive market forecast analyses focusing on a human West Nile virus (WNV) vaccine and an anti-WNV monoclonal antibody for seasonal pre-exposure prophylaxis. The scope of work includes epidemiologic data synthesis, health economic modeling, demand forecasting, financial return-on-investment analyses, and stakeholder engagement via structured interviews. The final findings must be disseminated through technically sound reports and peer-reviewed publications. The period of performance is 12 months, spanning from September 30, 2026, to September 29, 2027. The government has specified labor requirements including a Principal Investigator (150 hours), Postdoctoral Fellow (750 hours), Health Economist (300 hours), and Research Analyst (300 hours), along with a provision for non-conference travel. Award will be based on best value, with technical approach, management approach, organizational experience, and past performance weighted more heavily than price. All quotes must be submitted by September 2, 2026, at 10am EST to the Contracting Specialist. Offerors must provide a T&M quote, completed pricing for all CLINs, written acknowledgement of the Statement of Work, and proof of active SAM registration with a Unique Entity ID.
CDC Office Of Acquisition Services

POSTED

about 10 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541715
New
Federal
ManTech special Broad Agency Announcement (sBAA): Accelerating Maritime Modernization: Innovation in Naval Manufacturing, Sustainment, and Industrial Base Capability
Solicitation # N0001426SB002
The Navy Manufacturing Technology Program is seeking innovative research and development proposals through solicitation N0001426SB002 to enhance shipbuilding and maintenance capabilities by improving speed, throughput, and industrial base resilience. The focus is on transforming shipyards, maintenance depots, and supply chain operations through breakthrough manufacturing technologies that enable faster construction, arming, and repair of naval vessels. Proposals must clearly demonstrate how they remove existing bottlenecks and strengthen the nation’s shipbuilding enterprise by increasing efficiency, adaptability, and competitiveness across the defense industrial base. This initiative is critical to sustaining and modernizing the U.S. naval industrial infrastructure to meet current and future operational demands. Proposals are due by September 16, 2026, and are open to organizations responding to the Small Business Administration Assistance program under NAICS code 541715. The solicitation is managed by the Office of Naval Research in Arlington, Virginia, with primary point of contact Stephanie L. Marsh and secondary contact Miranda Fleck for inquiries. Performance locations are not specified, allowing flexibility for applicants to propose solutions that can be implemented across various U.S. naval manufacturing and maintenance facilities. Interested parties must submit their responses via the SAM.gov portal before the deadline to be considered for funding and collaboration opportunities aimed at revolutionizing naval manufacturing.
Office Of Naval Research

POSTED

1 day ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541380
Grant
Molecular and Genomic Laboratory TestingThe contract seeks a subcontractor to conduct advanced molecular and genomic testing on tissue samples from individuals with neurofibromatosis, specifically focusing on next-generation sequencing, RNA sequencing, and other related molecular profiling techniques. The work aims to generate detailed genetic and transcriptomic data to enhance understanding of the disease’s molecular mechanisms, with the expectation that results will support clinical or research initiatives tied to defense health programs. All testing must adhere to high standards of accuracy, reproducibility, and data integrity, with samples received from designated sources and processed under protocols that ensure traceability and quality control. The opportunity is posted under NAICS code 541380, indicating it is classified as other scientific and technical consulting services, and is issued by the Defense Health Agency Contracting Activity under the Department of Defense. Interested parties must submit proposals by the deadline of September 22, 2026, and the work is expected to be performed domestically though the exact location is not specified. The contract does not include set-aside provisions for small businesses or other designated categories, and there is no designated point of contact listed in the posting. Proposals should demonstrate technical expertise in genomic analysis, experience with clinical or research-grade tissue samples, and the capacity to deliver actionable data within stringent timelines.
Testing Laboratories and Services

POSTED

2 months ago

DEADLINE

in 26 days
View Details
NAICS: 541611
Grant
Clinical Trial Design and Biostatistical SupportThe contract seeks a subcontractor to provide comprehensive biostatistical consulting services in support of clinical and translational research initiatives, with a focus on study design, power analysis, randomization procedures, and the development of robust data analysis plans. The work is intended to ensure methodological rigor and statistical validity across defense-related health research projects, requiring expertise in applying statistical principles to real-world clinical trial scenarios. The contractor must be capable of tailoring statistical methodologies to the unique constraints and objectives of military and veteran health research environments. This opportunity is issued under the Defense Health Agency Contracting Activity, operating within the Department of Defense, and is classified under NAICS code 541611 for scientific research and development services. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026. Performance location details are not specified, indicating potential flexibility in execution, though the work must align with the Agency’s operational and research priorities. As a subcontract, this engagement is likely part of a larger research initiative, and proposers should be prepared to collaborate effectively with primary contractors and federal research teams to deliver timely, high-quality statistical support.
Administrative Management and General Management Consulting Services

POSTED

2 months ago

DEADLINE

in 26 days
View Details
NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Research and Development in Biotechnology

POSTED

2 months ago

DEADLINE

in 26 days
View Details